← All trials
NCT05226702
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 22, 2022
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Feb 7, 2022
- Last posted
- Aug 29, 2022
- Enrollment
- 380
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of SaskatchewanLead sponsor
- University of SaskatchewanReponsible party - principal investigator
- Government of CanadaCollaborator
- SEPPIC, ParisCollaborator
- Vaccine Formulation Institute (VFI)Collaborator
- Government of SaskatchewanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.